Mark Leid and Theresa Filtz, with collaborators at Erasmus University Medical Center, University of Leicester, University of Oxford, and the Skeletal Biology Laboratory at Oregon State published in Human Molecular Genetics A de novo substitution in BCL11B leads to loss of interaction with transcriptional complexes and craniosynostosis.
Dr. Dan Hartung, OSU/OHSU College of Pharmacy Faculty Dr. Dan Hartung – Featured Publication Dr. Dan Hartung, PharmD, MPH, was recently featured in JAMA for his study on buprenorphine coverage in Medicare Part D plans. Dr. Hartung explored the lacking use of buprenorphine and its possible linkage to insurance company cost-control measures such as step therapy or […]
Gut microbial metabolism of xanthohumol produces estrogenic metabolites, notably 8‐prenylnaringenin. In article number 1800923, Jan F. Stevens and co‐workers show that 8‐prenylnaringenin is not the end product of metabolism by gut microbes, shedding new light on the perceived pro‐estrogenicity of xanthohumol. Read more!
Dr. Aleksandra Sikora, lab members and collaborators from the World Health Organization have a publication in Molecular and Cellular Proteomics entitled “Quantitative proteomics of the 2016 WHO Neisseria gonorrhoeae reference strains surveys vaccine candidates and antimicrobial resistance determinants.”
Dr. Aleksandra Sikora, Ryszard Zielke, and lab members and collaborators announce a publication in PLOS Pathogens in July 2018: “SliC is a surface-displayed lipoprotein that is required for the anti-lysozyme strategy during Neisseria gonorrhoeae infection”
An article by Dr. Gaurav Sahay’s research group was highlighted on the front cover of the 1 August 2018 issue of “Molecular Therapy” entitled ”Lipid Nanoparticle Systems for Enabling Gene Therapies”